Clinical Trial: Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" Under Fed Conditions

U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07691268) titled 'Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" Under Fed Conditions' on June 25.

Brief Summary: Phase 1 study to evaluate the safety and the pharmacokinetics of "UI111" and "UIC202006" in healthy adult volunteers under fed state conditions

- Open-label, randomized, single-dose, 2-sequence, 4-period, crossover design

Study Start Date: Feb. 13, 2025

Study Type: INTERVENTIONAL

Condition: Dyslipidemia

Intervention: DRUG: Administration of UI111

1cap, once a day

DRUG: Administration of UIC202006

1cap, once a day

Recruitment Status: COMPLETED

Sponsor: Korea United Pharm. Inc.

Published by HT D...